Literature DB >> 870132

Tumour regression as a guide to prognosis: a study with experimental animals.

J Denekamp.   

Abstract

An analysis has been made of the relationship between regression during therapy and the probability of local control in a group of mice treated with single doses and fractionated doses of X rays. The tumours were first generation transplants from spontaneous mammary carcinomas in C3H mice and were irradiated with single doses 3F/4 days, 9F/10 days, 9F/18 days or 15F/18 days. The size of the smallest radiation dose approached those encountered in clinical radiotherapy. A significant correlation was observed between the shrinkage during the treatment period and the local control at 150 days, for three of the four fractionated schedules. A weaker correlation was observed for shrinkage within a week after single doses, and for shrinkage during treatment with nine fractions in 18 days. It is postulated that the rate of shrinkage is an inherent characteristic of each individual tumour and does not reflect the number of cells killed. However, the shrinkage in some tumours during the course of therapy may result in more extensive reoxygenation which makes these tumours more sensitive to subsequent doses of fractionated course. The degree of shrinkage within the period of fractionated irradiation was found to be a useful prognostic guide to ultimate local control in individual tumours.

Entities:  

Mesh:

Year:  1977        PMID: 870132     DOI: 10.1259/0007-1285-50-592-271

Source DB:  PubMed          Journal:  Br J Radiol        ISSN: 0007-1285            Impact factor:   3.039


  9 in total

1.  Advanced Small Animal Conformal Radiation Therapy Device.

Authors:  Sunil Sharma; Ganesh Narayanasamy; Beata Przybyla; Jessica Webber; Marjan Boerma; Richard Clarkson; Eduardo G Moros; Peter M Corry; Robert J Griffin
Journal:  Technol Cancer Res Treat       Date:  2016-07-08

2.  [A reply to the comment by K. R. Trott in Strahlenther. Onkol. 173 (1997), 146-147 on the article by Strnad et al.: "The regression of Yoshida sarcoma during normoxia and hypoxia after fractionated irradiation" in Strahlenther. Onkol. 173 (1997), 141-145].

Authors:  F Kamprad
Journal:  Strahlenther Onkol       Date:  1997-05       Impact factor: 3.621

3.  Sensitization of mouse tumours using fractionated X-irradiation.

Authors:  J Denekamp; F A Stewart
Journal:  Br J Cancer Suppl       Date:  1978-06

4.  [Regression of Yoshida sarcoma during normoxia and hypoxia after fractionated irradiation].

Authors:  V Strnad; F Kamprad; J Jahns; M Meyer; R Böhme; P Madaj-Sterba; M Kirschner; R Sauer
Journal:  Strahlenther Onkol       Date:  1997-03       Impact factor: 3.621

5.  In vivo follow-up of rat tumor models with 2-deoxy-2-[F-18]fluoro-D-glucose/dual-head coincidence gamma camera imaging.

Authors:  Jacques Monteil; Aurélie Dutour; Barbara Akla; Thierry Chianéa; Valérie Le Brun; Laurent Grossin; François Paraf; Yolande Petegnief; Jean-Claude Vandroux; Michel Rigaud; Franck G Sturtz
Journal:  Mol Imaging Biol       Date:  2005 May-Jun       Impact factor: 3.488

Review 6.  Assessment of the response of tumours to radiation: clinical and experimental studies.

Authors:  H D Suit; A M Walker
Journal:  Br J Cancer Suppl       Date:  1980-04

Review 7.  Can dose-survival parameters be deduced from in situ assays?

Authors:  T E Wheldon
Journal:  Br J Cancer Suppl       Date:  1980-04

Review 8.  Is any single in situ assay of tumour response adequate?

Authors:  J Denekamp
Journal:  Br J Cancer Suppl       Date:  1980-04

9.  Regression, recurrence and cure in an irradiated mouse tumour.

Authors:  A S Abdelaal; A H Nias
Journal:  J R Soc Med       Date:  1979-02       Impact factor: 18.000

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.